MSM is pleased to announce the appointment of Dr. Edward Kislauskis to its Scientific Advisory Board

03/25/2013

MSM is pleased to announce the appointment of Dr. Edward Kislauskis to its Scientific Advisory Board. Dr. Kislauskis is an expert in preclinical research and a recognized thought leader on the topic of animal models of human diseases. He co-founded Biomedical Research Models, Inc. (Worcester), Hygeia Therapeutics, Inc. (Holden), and Endocellutions, Inc. (Marshfield) where he is VP Research. Dr. Kislauskis is also active consultant to a growing number of life science companies. Dr. Albert Zlotnik, the Chairman of the SAB said, "MSM is at a critical juncture where expertise in pre-clinical development is crucial to the company's evolution. Dr. Kislauskis' expertise will prove invaluable to the Company's evolutions from a discovery phase company to a development company.